Beyond Herceptin, Dr. Slamon continues to be a leading figure in cancer research. He has contributed to the development of other targeted therapies and is involved in ongoing research to find new treatments for various types of cancer. His work has also influenced the broader field of oncology, encouraging a shift towards personalized medicine.
